APA

Olanow C. W., Factor S. A., Espay A. J., Hauser R. A., Shill H. A., Isaacson S., Pahwa R., Leinonen M., Bhargava P., Sciarappa K., Navia B. & Blum D. (20200715). Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study. : The Lancet. Neurology.

Chicago

Olanow C Warren, Factor Stewart A, Espay Alberto J, Hauser Robert A, Shill Holly A, Isaacson Stuart, Pahwa Rajesh, Leinonen Mika, Bhargava Parul, Sciarappa Ken, Navia Bradford and Blum David. 20200715. Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study. : The Lancet. Neurology.

Harvard

Olanow C. W., Factor S. A., Espay A. J., Hauser R. A., Shill H. A., Isaacson S., Pahwa R., Leinonen M., Bhargava P., Sciarappa K., Navia B. and Blum D. (20200715). Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study. : The Lancet. Neurology.

MLA

Olanow C Warren, Factor Stewart A, Espay Alberto J, Hauser Robert A, Shill Holly A, Isaacson Stuart, Pahwa Rajesh, Leinonen Mika, Bhargava Parul, Sciarappa Ken, Navia Bradford and Blum David. Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study. : The Lancet. Neurology. 20200715.